YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
112 hedge funds and large institutions have $225M invested in Y-mAbs Therapeutics in 2024 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
112
Holders Change
+7
Holders Change %
+6.67%
% of All Funds
1.49%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
18
Increased
39
Reduced
31
Closed
11
Calls
$50K
Puts
$8K
Net Calls
+$42K
Net Calls Change
-$516K
Top Buyers
1 |
CP
Caligan Partners
New York
|
+$4.48M |
2 |
LGM
Logos Global Management
San Francisco,
California
|
+$1.57M |
3 |
PBA
Paradigm Biocapital Advisors
New York
|
+$1.17M |
4 |
BFM
Boothbay Fund Management
New York
|
+$1.07M |
5 |
State Street
Boston,
Massachusetts
|
+$819K |